Plasmozytom, Myelom (C90) - Relative Überlebensraten in Österreich nach Geschlecht (1991-2018)
Diagnose-
periode1)
Risikopopulation2)Überleben nach Diagnose (in Jahren)
N13510
Insgesamt
1991-19951.26868,647,532,818,1
1996-20001.69866,444,530,719,9
2001-20051.94371,450,938,622,9
2006-20102.11575,957,945,226,2
2011-20152.04875,356,644,9-
2016-20181.36277,365,0--
Männer
1991-199556867,146,331,016,7
1996-200076269,648,833,522,0
2001-200593472,752,841,224,2
2006-20101.06378,260,249,428,2
2011-20151.06974,654,144,1-
2016-201876177,367,2--
Frauen
1991-199570069,848,434,319,1
1996-200093663,841,028,518,1
2001-20051.00970,149,336,121,7
2006-20101.05273,555,741,024,3
2011-201597976,059,345,9-
2016-201860177,262,3--